Chengxin Lithium Group Past Earnings Performance
Past criteria checks 0/6
Chengxin Lithium Group has been growing earnings at an average annual rate of 26.6%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 30.8% per year.
Key information
26.6%
Earnings growth rate
26.0%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 30.8% |
| Return on equity | -7.6% |
| Net Margin | -17.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Chengxin Lithium Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 4,821 | -854 | 468 | 10 |
| 30 Jun 24 | 5,772 | -96 | 544 | 9 |
| 31 Mar 24 | 6,381 | 95 | 468 | 9 |
| 31 Dec 23 | 7,951 | 702 | 460 | 10 |
| 30 Sep 23 | 10,529 | 2,297 | 458 | 10 |
| 30 Jun 23 | 11,664 | 3,145 | 381 | 11 |
| 31 Mar 23 | 13,136 | 4,946 | 378 | 21 |
| 01 Jan 23 | 12,039 | 5,552 | 373 | 19 |
| 30 Sep 22 | 9,176 | 4,672 | 301 | 21 |
| 30 Jun 22 | 6,945 | 3,597 | 272 | 21 |
| 31 Mar 22 | 4,164 | 1,829 | 228 | 10 |
| 01 Jan 22 | 3,017 | 866 | 178 | 9 |
| 30 Sep 21 | 2,291 | 520 | 120 | 3 |
| 30 Jun 21 | 2,243 | 482 | 128 | 1 |
| 31 Mar 21 | 2,088 | 191 | 150 | 21 |
| 31 Dec 20 | 1,791 | 27 | 166 | 30 |
| 30 Sep 20 | 2,047 | -86 | 241 | 44 |
| 30 Jun 20 | 1,972 | -285 | 242 | 47 |
| 31 Mar 20 | 1,996 | -135 | 219 | 29 |
| 31 Dec 19 | 2,279 | -59 | 223 | 21 |
| 30 Sep 19 | 2,377 | 61 | 201 | 7 |
| 30 Jun 19 | 2,456 | 110 | 186 | 3 |
| 31 Mar 19 | 2,569 | 123 | 189 | 2 |
| 31 Dec 18 | 2,518 | 108 | 178 | 0 |
| 30 Sep 18 | 2,396 | 133 | 185 | 0 |
| 30 Jun 18 | 2,268 | 76 | 187 | 0 |
| 31 Mar 18 | 2,188 | 29 | 184 | 0 |
| 31 Dec 17 | 2,018 | 26 | 173 | 0 |
| 30 Sep 17 | 1,903 | 100 | 167 | 0 |
| 30 Jun 17 | 1,696 | 95 | -31 | 0 |
| 31 Mar 17 | 1,457 | 60 | 167 | 0 |
| 31 Dec 16 | 1,402 | 23 | 176 | 0 |
| 30 Sep 16 | 1,369 | -206 | 180 | 0 |
| 30 Jun 16 | 1,348 | -252 | 377 | 0 |
| 31 Mar 16 | 1,409 | -227 | 186 | 0 |
| 31 Dec 15 | 1,440 | -195 | 196 | 0 |
| 30 Sep 15 | 1,502 | -43 | 169 | 0 |
| 30 Jun 15 | 1,587 | 0 | 184 | 0 |
| 31 Mar 15 | 1,655 | 14 | 188 | 0 |
| 31 Dec 14 | 1,715 | 11 | 187 | 0 |
| 30 Sep 14 | 1,764 | 13 | 202 | 0 |
| 30 Jun 14 | 1,761 | 9 | 193 | 0 |
| 31 Mar 14 | 1,764 | 13 | 196 | 0 |
| 31 Dec 13 | 1,778 | 10 | 190 | 0 |
Quality Earnings: 002240 is currently unprofitable.
Growing Profit Margin: 002240 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002240 is unprofitable, but has reduced losses over the past 5 years at a rate of 26.6% per year.
Accelerating Growth: Unable to compare 002240's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 002240 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-5.3%).
Return on Equity
High ROE: 002240 has a negative Return on Equity (-7.56%), as it is currently unprofitable.